4Frable WJ,Austin RM,Collins RJ,et al.Medicolegal affairs:IAC task force summary.Acta Cytol,1998,42(1):76-119
5Lee KR,Ashfaq R,Birdsong GG,et al.Comparison of conventional Papanicolaou smears and a fluid-based thirrlayer system for cervical cancer screening.Obstet Gynecol,1997,90(2):278-284
6Papillo JF,Zarka MA,St John TL.Evaluation of the Thinprep Paptest in clinical practice:a seven-month,16,314-case experience in northern Vermont.Acta Cytol,1998,42(1):203-208
7Tezuka F,Shuki H,Oikawa H,et al.Numerical counts of epithelial cells collected,smeared and lost in the conventional Papanicolaou smear preparation.Acta Cytol,1995,39(3):837-838
8Belinson J,Qiao YL,Pretorius R,et al.Prevalence of cervical cancer and feasibility of screening in rural China:a pifor study for the Shanxi province cervical cancer screening study.Int J Gynecol Cancer,1999,9(2):411-417
9Mario P,Irena J,Katja S,et al.Hybrid Capture Ⅱ HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail[J].Journal of Clinical Viology,2002,41(15):89.
10Chan JK, Jeongmi KJ, Misun P, et al. HPV oligonucleotide microarray-based detection of HPV genotypes in cervical neoplastic lesions[J].Gynecol Oncol 2003,89:210.
